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p27Kip1: A haploinsufficient tumor suppressor
JAMES ROBERTS
Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
The catalytic activity of cyclin-dependent kinases mutation or silencing of the remaining wild-type allele.
Hence, p27 is a haploinsufficient tumor suppressor. The(CDKs) is regulated by both the association with regula-
simplifying assumption that inactivating mutations of tu-tory subunits and phosphorylation. Activating subunits
mor suppressor genes are strictly recessive may haveare called cyclins, and inhibitory subunits are called CDK
excluded an important class of genes that displayinhibitors (CKIs). One CKI, p27Kip1, seems particularly
haploinsufficiency.important in coupling cell proliferation to extracellular
mitogenic stimuli. Thus, in normal proliferating cells,
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CAKs and CAKAKS: CDK activation in fission yeast and
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Cyclin-dependent protein kinases (CDKs) are the progression and is conserved among species from yeast
to humans, the enzyme responsible for activation hasprincipal molecular triggers of the cell division cycle and
are strictly controlled by both positive and negative regu- diverged between budding yeast and higher eukaryotes.
Mammalian CAK is itself a CDK, composed of a cata-lators. The activation of CDK-cyclin complexes requires
phosphorylation of the catalytic subunit by a CDK-acti- lytic subunit, CDK7, that forms binary complexes with
cyclin H, and ternary complexes with cyclin H and thevating kinase (CAK). Although this activating phosphor-
ylation step is common to all CDKs involved in cell cycle assembly factor MAT1. The trimeric complex also partic-
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ipates in transcriptional regulation, as a component of are investigating whether or not this mechanism operates
in cycling mammalian cells in culture. In S. pombe, ge-transcription factor TFIIH. A physiological role for CDK7
in activating CDKs and promoting cell cycle progression netic studies by Beach et al identified a nonessential
kinase, Csk1, that seemed to stimulate the kinase associ-has now been firmly established by studies of a CDK7
homologue in Drosophila. In budding yeast, CAK activ- ated with Mcs2, the fission yeast homologue of cyclin H.
We therefore constructed baculoviruses to overexpressity is supplied by a distinct single-subunit protein kinase,
Cak1, whereas Kin28, the closest homologue of CDK7, Mcs6 (the CDK7 homologue), Mcs2, and Csk1 (the po-
tential CAKAK) for biochemical studies in vitro. Re-functions solely in transcription. A CAK in the fission
yeast, Schizosaccharomyces pombe, the Mcs6-Mcs2 com- markably, Csk1 is indeed a potent CAKAK in vitro. We
have also combined temperature-sensitive mutations inplex, closely resembles the metazoan enzyme and so
presents a novel opportunity to study CDK activation mcs6 and mcs2 with a Dcsk1 null mutation; the resulting
growth retardation (or arrest in the presence of an addi-in a genetically tractable organism. We are investigating
the regulatory pathways upstream of CAK by a combina- tional mutation, cdc2-3W) suggests more severe compro-
mise of CDK activation when both functions are defec-tion of biochemical and genetic strategies in both mam-
malian cells and fission yeast. tive. We are also investigating how MAT1 influences the
activity of the trimeric CAK complex. We have estab-The two major forms of CDK7 in mammalian cells—
the dimer and the trimer—may be assembled by distinct lished stable mammalian cell lines that conditionally ex-
press MAT1 in both wild-type and various mutant forms.molecular mechanisms. A stable association between
CDK7 and cyclin H in a binary complex requires phosphor- This will allow us to search for novel protein targets of
MAT1 that would be candidate substrates for CDK7.ylation of CDK7 by a CAK-activating kinase (CAKAK),
whereas ternary complex assembly and activation can Finally, we are comparing the substrate specificities and
other enzymatic properties of pure dimeric and trimericoccur in the absence of phosphorylation through the
action of MAT1. Thus, to understand the mechanisms CAK generated in insect cells using baculoviruses, with
several known substrates that may be important for cellcontrolling CAK function, we are pursuing two major
lines of investigation: the identification and characteriza- cycle control, transcription, or other processes.
tion of CAKAKS, both in vitro and in vivo, and a system-
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Regulation of the yeast cell cycle by transcription and
proteolysis of cyclin-dependent kinase regulators
FRED CROSS1 and KRISTI LEVINE
The Rockefeller University, New York, New York USA
Events in the budding yeast cell cycle are driven by through the cell cycle such that peak abundance of the
regulators corresponds closely with their natural timecyclical accumulation and destruction of cyclin-depen-
of function. There are at least three major points ofdent kinase (CDK) activators (cyclins) and inhibitors.
transcriptional control: in postmitotic prereplicativeTranscription of most of these regulators is controlled
cells, in cells committed to cell cycle initiation, and in
cells that have completed DNA replication and are pre-
paring for mitosis. At all three points, positive feedback1 Speaker and participant
